Microba Life Sciences has launched its next-generation testing product range, MetaXplore, under Co-Biome, a new brand.

Launched in Australia, the new human gut microbiome testing product range provides diagnostic gastrointestinal health testing and metagenomic-driven gut microbiome analysis to provide healthcare professionals with comprehensive gastrointestinal testing solutions.

The test range can be accessed by healthcare professionals in the country through Co-Biome.

Following its launch in Australia, Microba plans to roll out the product range through its growing worldwide distribution partner network.

Microba Life Sciences CEO Dr Luke Reid said: “The new MetaXplore test range delivers an important advancement in how microbiome test information can be applied in a healthcare setting.

“We continue to make progress at the forefront of this field to advance the application of microbiome testing in a healthcare setting towards a future where it can be routine in health and disease management, much like a blood test is today.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The MetaXplore test range comprises MetaXplore, MetaXplore GI and MetaXplore GI Plus products.

Key features of the range include an easy-to-interpret report format that is designed for healthcare professionals as well as scientifically graded clinical insights that use guidelines from the National Health and Medical Research Council.

Other features include diagnostic and investigative gastrointestinal health markers, diagnostic pathogen and parasite detection, complete microbiome profiling, and microbiome production and consumption of metabolites.

Microba chief scientific officer associate professor Lutz Krause said: “These new tests integrate traditional gastrointestinal pathology tools with Microba’s next-generation microbiome testing technology and the latest global research to significantly advance the utility of microbiome testing in a healthcare setting.”